A new highly lipophilic methylgermanium(IV)porphyrin; dimethyl-5,10,15,20-tetrakis[3′,5′-bis(1″,1″-dimethylethyl)phenyl]porphynatogermanium(IV) (Abbr. MGP), has been prepared and characterized. The isolated compound showed considerable activity toward neoplastic tissues both in vitro and in vivo.
No takes yet. Share an insight, caveat, or question.
Miyamoto et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: